Skip to content
Aswath Damodaran cover art

All episodes

Aswath Damodaran, 788 episodes. Page 5 of 8.

#
Title
401

The Compressed Tech Life Cycle: The Management Handbook

402

Session 16 (Val MBAs): intrinsic Value - Heading to closure!

403

Session 18 (Val Undergrad): Valuing Declining, Financial Service and Emerging Market firms

404

Session 17: The Debt/Equity Trade off

405

Aging in Dog Years? The Short and Glorious Life of a Tech Company

406

Session 17 (Val MBAs): Pricing 101

407

Session 19 (Val Undergrad): Valuation Closure and Pricing 101

408

Yahoo: The End Game?

409

Session 18: Optimizing the Debt Mix

410

Session 23: Distressed Equity as an option

411

Session 18 (Val MBAs): More on Pricing - Descriptional and Analytical Tests

412

Session 22: The Options to Delay and Expand

413

Session 20 (Val Undergrad): Pricing - Descriptional and Analytical Tests

414

Session 21: Introduction to Real Options

415

Session 19: Optimizing Financing Mix (Continued)

416

Session 20: Private Company, IPO and VC valuation

417

Session 19 (Val MBAs): More on Pricing - Applications

418

Botox, Viagra or Placebo?: The Pfizer Allergan Deal

419

Session 21 (Val Undergrad): Pricing - Peer Groups and Controlling for Differences

420

Session 19: Closing the Relative Valuation Book and Asset-based Valuation

421

Session 20: Optimizing Debt Mix - APV and Peer Group Pressure

422

Runaway Stories and Fairy Tale Endings: The Cautionary Tale of Theranos

423

Session 20 (Val MBAs): Asset Based Valuation and First Steps on Private Business Valuation

424

Checkmate or Stalemate: Valeant's fall from investing grace

425

Session 22 (Val Undergrad): Asset-based and Private company valuation

426

Divergence: The Changing Drug Business

427

Session 21: Debt Design

428

Session 18: Comparables and Controlling for Pricing Differences

429

Session 21 (Val MBAs): Valuing Private Companies and IPOs

430

Session 17: Pricing - Distribution and Determinants

431

Session 23 (Val Undergrad): Private Company and IPO Valuation

432

Session 16: Introduction to Relative Valuation (Pricing)

433

Session 22: Dividends - First Steps (Quiz shortened)

434

Session15: The Last Pieces of Intrinsic Value and First Steps on Pricing

435

Session 22 (Val MBAs): Introduction to options

436

Session 14: More valuations on the dark side

437

Session 24 (Val Undergrad): Introduction to Real Options

438

Session 13: First Valuations

439

Session 23: Good and Bad Reasons for paying dividends

440

Session 12: More Loose Ends and Narrative and Numbers

441

Session 23 (Val MBAs): Real Option Applications

442

Big Deal but is it a good deal? The ABInBev Acquisition of SABMiller

443

Session 25 (Val Undergrad): Real Option Applications - Patents and Natural Resource Reserves

444

The Future of the Ride Sharing Business: Playing Pundit!

445

A Price Premium for the Prancing Horse: The Ferrari IPO

446

Session 24 (Val MBAs): Distressed Equity as an Option + Acquirers' Anonymous

447

Session 11: Choose a DCF Model and Loose Ends in Valuation

448

Session 26 (Val Undergrad): Distressed Equity as an Option and Acquirers' Anonymous

449

Lyft on or Lyft off? The Other Ride Sharing Companies

450

Session 25: Valuation - The Last Frontier!

451

The Corporate Life Cycle: Investing, Finance and Management Lessons

452

Session 27 (Val Undergrad): Acquisitions Completed and Value Enhancement

453

Session 10: Fundamental Growth and Terminal Value

454

Session 25 (Val MBAs): Acquisitions (Completed) and Value Enhancements!

455

Session 26: The Fat Lady is Singing!

456

Session 9: Analyst Estimates of Growth and Fundamental Growth

457

Session 26 (Val MBAs): The Grand Finale!

458

Session 8: From Earnings to Cash Flows

459

Session 28 (Val Undergrad): Closing the sale!

460

Session 7: Estimating Earnings

461

The Corporate Life Cycle: Implications for Managing and Investing

462

The Price of Scandal: Sturm und Drang at Volkswagen

463

Country Risk: The 2024 Update

464

The Corporate Life Cycle: The Key Ideas

465

Session 5: ERP and Relative Risk Measures

466

Chapter/Session 1: The Search for a Unifying Theory

467

No happy ending? My Vale Journey

468

Chapter/Session 2: The Corporate Life Cycle - Basics

469

Chapter/Session 3: The Corporate Life Cycle - Measures and Determinants

470

Chapter/Session 4: Corporate Life Cycle - Transitions

471

The Uber Narrative Rollercoaster: A Wild Ride!

472

Chapter/Session 5: Corporate Finance 101

473

The Naming Game

474

Chapter/Session 6: Business Investing across the Life Cycle

475

Session 2: The Bermuda Triangle of Valuation and the big picture

476

Chapter/Session 8: Cash Return (Dividends) across the Life Cycle

477

The Fed did it!

478

Chapter/Session 7: Business Financing across the Life Cycle

479

Chapter/Session 9: Valuation and Pricing 101

480

The Macro Delusion and Pricing Bubbles: The Good, Bad and the Ugly!

481

Chapter/Session 10: Valuing and Pricing Start-ups and Young High Growth Firms

482

What is this class about?

483

Chapter/Session 11: Valuing Growth Firms

484

Session 26: The Grand Finale

485

Chapter/Session 12: Valuing Mature Firms

486

Session 26: Closing and Review

487

Chapter/Session 13: Valuing and Pricing Declining Firms

488

Session 25: Value Enhancement

489

Chapter/Session 14: Investment Philosophies 101

490

Session 25: More on valuation

491

Chapter/Session 15: Investing in Youth

492

Session 24: Acquisition Valuation

493

Chapter/Session 20: Lessons for the Road

494

Session 24: Closing the books on dividends and First steps on value

495

Chapter/Session 19: Aging with grace!

496

Chapter/Session 18: Managing across the life cycle

497

In Practice Webcast #13: Dividend Assessment

498

Chapter/Session 17: Investing in Decline

499

In Practice Webcast #12: The Trade off on Dividends

500

Chapter/Session 16: Investing in Middle Age